Skip to main content
Premium Trial:

Request an Annual Quote

Not Like it Used to Be

In a Q&A-style interview, Stratatech Corporation President Russ Smestad tells the Wisconsin State Journal that his career path — entering the biotech industry on the ground floor and moving up to start his own company — "would be difficult to replicate today." Smestad was hired by Cetus Madison in 1982, a time when "the biotech industry was really being formed," he says. "It was not like one could hire people already with a track record in this space."

Now, as president of Stratatech and chief operating officer of Biotech Profiles, an online database he launched to track Madison-area biotechs, Smestad says the industry looks much different. "There have been a lot of acquisitions of what I call mid-tier companies. The large companies are prospering; the small companies are stable; but our mid-tier is getting smaller," he says. These days, he adds, "it is tough for any early-stage biotech company."

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.